This information was published on 2020-08-20T00:33:46 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2076886 |
| (220) |
19 Mar 2020
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of arthritis; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of rheumatism; pharmaceutical products for ankylosing spondylitis; pharmaceutical products for the treatment of psoriatic arthritis; pharmaceutical products for the treatment of Juvenile idiopathic arthritis; pharmaceutical products for the treatment of Juvenile idiopathic psoriasis; pharmaceutical preparations; pharmaceutical preparations acting on the central nervous system; pharmaceutical agents affecting peripheral nervous system; pharmaceutical agents affecting sensory organs; cardiovascular pharmaceutical preparations; hormones for medical purposes; amino acids for medical purposes; amino acids for veterinary purposes; pharmaceutical agents affecting metabolism; pharmaceutical agents for treating physically caused lesions; antibiotic preparations; pharmaceutical preparations for immunity adjustment; analgesics; veterinary preparations; fungicides; pesticides; herbicides |
| (540) | Hyruan ONE |
| (550) | Word |
| (730) |
LG Chem, Ltd.
|
| (750) |
FB Rice Pty Ltd
|
Find out more about publications on the About page.